Clinical trial
A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and…
NCT00261911 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00261911 |
|---|---|
| Title | A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety. |
| Official title | A 12 Month Study to Assess Safety and Efficacy of Meridia (Sibutramine Hydrochloride Monohydrate) 10 and 15 mg in Obese Adolescents |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | sibutramine |
| Enrollment | 498 |
| Start date | Jul 1, 2000 |
| Completion | Feb 1, 2002 |
| First posted | Dec 6, 2005 |
| Last update posted | Aug 31, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: